295 related articles for article (PubMed ID: 15967043)
1. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours.
Lo Muzio L; Campisi G; Farina A; Rubini C; Ferrari F; Falaschini S; Leonardi R; Carinci F; Stalbano S; De Rosa G
Anticancer Res; 2006; 26(2B):1343-9. PubMed ID: 16619543
[TBL] [Abstract][Full Text] [Related]
4. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
[TBL] [Abstract][Full Text] [Related]
5. The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
Wang X; Zhang J; Fan M; Zhou Q; Deng H; Aisharif MJ; Chen X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):547-54. PubMed ID: 19327640
[TBL] [Abstract][Full Text] [Related]
6. Effect of p63 expression on survival in oral squamous cell carcinoma.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
[TBL] [Abstract][Full Text] [Related]
8. Effect of c-Met expression on survival in head and neck squamous cell carcinoma.
Lo Muzio L; Farina A; Rubini C; Coccia E; Capogreco M; Colella G; Leonardi R; Campisi G; Carinci F
Tumour Biol; 2006; 27(3):115-21. PubMed ID: 16612144
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
[TBL] [Abstract][Full Text] [Related]
10. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.
Hung KF; Chang CS; Liu CJ; Lui MT; Cheng CY; Kao SY
J Oral Pathol Med; 2006 Nov; 35(10):589-94. PubMed ID: 17032390
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
13. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
18. Expression of Eps8 correlates with poor survival in oral squamous cell carcinoma.
Chu PY; Liou JH; Lin YM; Chen CJ; Chen MK; Lin SH; Yeh CM; Wang HK; Maa MC; Leu TH; Chang NW; Hsu NC; Yeh KT
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e77-81. PubMed ID: 22897151
[TBL] [Abstract][Full Text] [Related]
19. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]